Trump Finally Has Enough of the Podcast People
Trump Declares Iran War Over
Little Kids, Big Government
Hasan Piker Resists an Image Repair Job; Vanity Fair Proves Few Care About...
You Can't Want It More Than They Do
Eric Swalwell Finds Out About Sudden 'Investigative Reporting'
A Republican Governor in California?
Tim Tebow Is Doing the Government's Job
The False Promise of App Store Age Verification
The Story of Everything and Beyond
Arizona Republicans Supporting the Completion of President Trump's Border Wall
The Bible Belongs in Public School Readings
Record Tax Relief the Left Didn’t Want You to Have
Callaway Just Launched an Awesome New Line of Gear for America's 250th Birthday
Erika Kirk Cancels Appearance at Event After Threats on Her Life
Tipsheet

The CDC Director Just Gave Us an Updated Vaccine Timeline

The CDC Director Just Gave Us an Updated Vaccine Timeline
AP Photo/Alex Brandon

We've brought you a lot of exciting vaccine news these past few weeks. And there's more of it on Tuesday. Center for Disease Control Director Robert Redfield said Americans should expect a vaccine to be rolled out very, very soon. He predicted the second week of December.

Advertisement

The next question then is, who will be receiving the first doses. He answered that too.

In an interview with Fox News anchor Dana Perino, Redfield shared that the first groups to get the vaccine will probably be "nursing home residents and then some combination of health care providers and individuals at high risk for a poor outcome."

"I do think we'll have about 40 million doses of vaccine before the end of the...year," Redfield continued. "That's enough to vaccinate 20 million people. But then it will continue through January and February and hopefully by March we'll start to see vaccine available for the general public."

Advertisement

Pfizer, who vaccine its been developing with BioNTech has produced a 95 percent efficacy rate, requested an emergency authorization from the FDA. A second vaccine candidate being produced by Moderna isn't too far behind, reporting a 94 percent effectiveness. And then a third, developed by AstraZeneca, is up to 90 percent effective.

The FDA has reportedly scheduled a meeting for Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's request.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement